ILEVRO
ILEVRO
Approved
DIN Number
02411393
Drug Class
Human
Market Date
Jun 1, 2014
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02411393
AIG Number0152459002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01BC10 NEPAFENAC
Product Specifications
Dosage FormSuspension
Route of AdministrationOphthalmic
AHFS Classification52:08.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
NEPAFENACActive
Strength: 0.3 % / W/V
Monograph: NEPAFENAC